AsthmaNCT07411040
Effects of Body Awareness Therapy on Physical and Psychosocial Outcomes in Adults With Asthma
A study testing Body Awareness Therapy and Standart Care in people with Asthma, run by Recep Tayyip Erdogan University.
Trial summary
This study aims to investigate the effects of Body Awareness Therapy on physical and psychosocial outcomes in adults with asthma. Asthma is a chronic respiratory condition that can affect breathing, physical activity, and emotional well-being. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Asthma
- What is being tested?
- Body Awareness Therapy and Standart Care
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 67 participants
- Where
- No sites listed yet
- Study dates
- 1 Feb 2026to 1 May 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults aged between 18 and 65 years.
- Clinically diagnosed asthma confirmed by a physician.
- Stable asthma condition (no acute exacerbation in the last 4 weeks).
- Receiving regular medical treatment for asthma.
- Able to understand and follow instructions for the intervention.
- Willing to participate and provide written informed consent.
Who cannot join
- Diagnosis of chronic respiratory diseases other than asthma (e.g., COPD, bronchiectasis).
- Acute asthma exacerbation within the last 4 weeks.
- Severe cardiovascular, neurological, or musculoskeletal conditions that may limit participation in physical activity.
- Current participation in another structured exercise or rehabilitation program.
- History of major psychiatric disorders that may interfere with participation (e.g., psychotic disorders).
- Pregnancy.
- Cognitive impairment affecting the ability to follow instructions.
About this study
Official title: Effect of Body Awareness Therapy on Physical and Psychosocial Outcomes in Adults With Asthma: A Randomized Controlled Trial
This study aims to investigate the effects of Body Awareness Therapy on physical and psychosocial outcomes in adults with asthma. Asthma is a chronic respiratory condition that can affect breathing, physical activity, and emotional well-being. In addition to medical treatment, non-pharmacological approaches that support body awareness and breathing may help individuals manage their symptoms more effectively.
Participants in this study will be randomly assigned to either a Body Awareness Therapy group or a control group receiving standard care. The Body Awareness Therapy program includes guided exercises focusing on posture, breathing, movement, and awareness of bodily sensations. The program will be delivered over several weeks by a trained physiotherapist.
The main outcomes of the study include physical function, respiratory symptoms, quality of life, psychological well-being, and body awareness levels. The results of this study are expected to provide evidence on whether Body Awareness Therapy can be an effective supportive approach in asthma management and rehabilitation.
Read the detailed description
This study is designed to evaluate the effectiveness of Body Awareness Therapy as a complementary intervention for adults with asthma. Asthma is a chronic inflammatory airway disease that not only affects respiratory function but is also associated with reduced physical capacity, increased symptom perception, psychological distress, and decreased quality of life. While pharmacological treatment is essential for asthma management, many individuals continue to experience persistent symptoms and psychosocial challenges despite optimal medical care.
Body Awareness Therapy is a mind-body approach that emphasizes conscious attention to bodily sensations, breathing patterns, posture, and movement. The therapy aims to improve self-regulation, enhance interoceptive awareness, and promote more efficient and relaxed breathing. Previous research in other chronic conditions suggests that body-based interventions may positively influence physical function, symptom perception, emotional well-being, and coping strategies. However, evidence regarding the use of Body Awareness Therapy in individuals with asthma remains limited.
In this randomized controlled trial, eligible participants will be randomly allocated to either a Body Awareness Therapy group or a control group receiving standard care. The intervention will consist of supervised sessions conducted by a trained physiotherapist over a predefined period. The sessions will include guided exercises focusing on breathing awareness, postural alignment, gentle movement, and attention to bodily sensations. Participants will also be encouraged to apply these principles in daily life.
The primary outcomes of the study include physical function and asthma-related symptoms. Secondary outcomes include psychological well-being, quality of life, and levels of body awareness. Outcome measures will be assessed at baseline and after completion of the intervention period.
The findings of this study are expected to contribute to the growing field of non-pharmacological and mind-body interventions in respiratory rehabilitation. If effective, Body Awareness Therapy may represent a low-cost, safe, and accessible supportive approach to improve both physical and psychosocial health in individuals with asthma.
- Conditions
- Asthma
- Being tested
- Body Awareness Therapy, Standart Care
- Keywords
- asthma, body awareness, body awareness therapy
- Medical subject headings
- Asthma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Body Awareness TherapyBehavioural
A structured Body Awareness Therapy program delivered by a trained physiotherapist, including guided exercises focusing on breathing awareness, posture, gentle movement, and attention to bodily sensations.
Standart CareOther
Participants will continue their usual medical care for asthma without additional body awareness intervention.
| Study group | Role | What they receive |
|---|---|---|
| Body Awareness Therapy Group | Experimental | Participants will receive a structured Body Awareness Therapy program delivered by a trained physiotherapist. Receives: Behavioral: Body Awareness Therapy; Other: Standart Care |
| Standard Care Control Group | Active comparator | Participants will receive standard medical care for asthma without additional body awareness intervention. Receives: Other: Standart Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Six-Minute Walk Test Distance
Physical function will be assessed using the Six-Minute Walk Test (6MWT). Total walking distance covered in six minutes will be recorded. (Units of Measure:
Meters)
Measured: Baseline (Week 0) and Post-intervention (Week 8)
Asthma Control Test Total Score
Asthma symptom severity will be assessed using the Turkish Asthma Control Test (T-ACT). The total questionnaire score will be analyzed.
Measured: Baseline (Week 0) and Post-intervention (Week 8)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Feb 2026
- Study start1 Feb 2026 (estimated)
- Primary completion1 Apr 2026 (estimated)
- Study completion1 May 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AsthmaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomly assigned to one of two parallel groups: an intervention group receiving Body Awareness Therapy and a control group receiving standard care. Outcomes will be compared between groups at baseline and after completion of the intervention period.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 67 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Recep Tayyip Erdogan University
- Sponsor type
- University, hospital or other
- Collaborators
- İstanbul Yeni Yüzyıl Üniversitesi
- Responsible party
- Principal investigator, Seda Karaca, Recep Tayyip Erdogan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07411040
- Sponsor's protocol ID
- 2026/01-1819
- Status last verified
- Feb 2026
- First submitted
- 31 Jan 2026
- Last updated
- 13 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) will not be shared publicly due to ethical and privacy considerations, as the data include sensitive personal and health-related information. Data will be used only for the purposes of the current study and stored in accordance with institutional and data protection regulations.
Study at a glance
From the registry record, last updated by the sponsor on 13 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Body Awareness Therapy on Physical and Psychosocial Outcomes in Adults With Asthma: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07411040
- Acronym / sponsor ID
- 2026/01-1819
- Conditions
- Asthma
- Keywords
- asthma, body awareness, body awareness therapy
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 67 participants (estimated)
- Lead sponsor
- Recep Tayyip Erdogan UniversityUniversity, hospital or other
- Collaborators
- İstanbul Yeni Yüzyıl Üniversitesi
- Study start
- 1 Feb 2026 (estimated)
- Primary completion
- 1 Apr 2026 (estimated)
- Study completion
- 1 May 2026 (estimated)
- First posted
- 13 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate the effects of Body Awareness Therapy on physical and psychosocial outcomes in adults with asthma. Asthma is a chronic respiratory condition that can affect breathing, physical activity, and emotional well-being. In addition to medical treatment, non-pharmacological approaches that support body awareness and breathing may help individuals manage their symptoms more effectively.
Participants in this study will be randomly assigned to either a Body Awareness Therapy group or a control group receiving standard care. The Body Awareness Therapy program includes guided exercises focusing on posture, breathing, movement, and awareness of bodily sensations. The program will be delivered over several weeks by a trained physiotherapist.
The main outcomes of the study include physical function, respiratory symptoms, quality of life, psychological well-being, and body awareness levels. The results of this study are expected to provide evidence on whether Body Awareness Therapy can be an effective supportive approach in asthma management and rehabilitation.
Detailed description
This study is designed to evaluate the effectiveness of Body Awareness Therapy as a complementary intervention for adults with asthma. Asthma is a chronic inflammatory airway disease that not only affects respiratory function but is also associated with reduced physical capacity, increased symptom perception, psychological distress, and decreased quality of life. While pharmacological treatment is essential for asthma management, many individuals continue to experience persistent symptoms and psychosocial challenges despite optimal medical care.
Body Awareness Therapy is a mind-body approach that emphasizes conscious attention to bodily sensations, breathing patterns, posture, and movement. The therapy aims to improve self-regulation, enhance interoceptive awareness, and promote more efficient and relaxed breathing. Previous research in other chronic conditions suggests that body-based interventions may positively influence physical function, symptom perception, emotional well-being, and coping strategies. However, evidence regarding the use of Body Awareness Therapy in individuals with asthma remains limited.
In this randomized controlled trial, eligible participants will be randomly allocated to either a Body Awareness Therapy group or a control group receiving standard care. The intervention will consist of supervised sessions conducted by a trained physiotherapist over a predefined period. The sessions will include guided exercises focusing on breathing awareness, postural alignment, gentle movement, and attention to bodily sensations. Participants will also be encouraged to apply these principles in daily life.
The primary outcomes of the study include physical function and asthma-related symptoms. Secondary outcomes include psychological well-being, quality of life, and levels of body awareness. Outcome measures will be assessed at baseline and after completion of the intervention period.
The findings of this study are expected to contribute to the growing field of non-pharmacological and mind-body interventions in respiratory rehabilitation. If effective, Body Awareness Therapy may represent a low-cost, safe, and accessible supportive approach to improve both physical and psychosocial health in individuals with asthma.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Participants will be randomly assigned to one of two parallel groups: an intervention group receiving Body Awareness Therapy and a control group receiving standard care. Outcomes will be compared between groups at baseline and after completion of the intervention period.
| Arm | Type | Receives |
|---|---|---|
| Body Awareness Therapy Group | Experimental | Behavioral: Body Awareness Therapy, Other: Standart CareParticipants will receive a structured Body Awareness Therapy program delivered by a trained physiotherapist. |
| Standard Care Control Group | Active comparator | Other: Standart CareParticipants will receive standard medical care for asthma without additional body awareness intervention. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Adults aged between 18 and 65 years.
- Clinically diagnosed asthma confirmed by a physician.
- Stable asthma condition (no acute exacerbation in the last 4 weeks).
- Receiving regular medical treatment for asthma.
- Able to understand and follow instructions for the intervention.
Key exclusion criteria (7 listed)
- Diagnosis of chronic respiratory diseases other than asthma (e.g., COPD, bronchiectasis).
- Acute asthma exacerbation within the last 4 weeks.
- Severe cardiovascular, neurological, or musculoskeletal conditions that may limit participation in physical activity.
- Current participation in another structured exercise or rehabilitation program.
- History of major psychiatric disorders that may interfere with participation (e.g., psychotic disorders).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Body Awareness TherapyA structured Body Awareness Therapy program delivered by a trained physiotherapist, including guided exercises focusing on breathing awareness, posture, gentle movement, and attention to bodily sensations. | Behavioural | Body Awareness Therapy Group |
| Standart CareParticipants will continue their usual medical care for asthma without additional body awareness intervention. | Other | Body Awareness Therapy Group, Standard Care Control Group |
Primary outcome
Six-Minute Walk Test Distance
Time frame: Baseline (Week 0) and Post-intervention (Week 8)
Physical function will be assessed using the Six-Minute Walk Test (6MWT). Total walking distance covered in six minutes will be recorded. (Units of Measure: Meters)
Asthma Control Test Total Score
Time frame: Baseline (Week 0) and Post-intervention (Week 8)
Asthma symptom severity will be assessed using the Turkish Asthma Control Test (T-ACT). The total questionnaire score will be analyzed.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Feb 2026.
- Individual participant dataSharing planned: No. Individual participant data (IPD) will not be shared publicly due to ethical and privacy considerations, as the data include sensitive personal and health-related information. Data will be used only for the purposes of the current study and stored in accordance with institutional and data protection regulations.
Related trials for Asthma
RecruitingPhase 1
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
Asthma
RecruitingPhase 1
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Asthma, Mild Asthma
RecruitingPhase 3
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Asthma Control
Active, not recruitingPhase 2/3
Local Antibiotic Delivery for Community Acquired Pneumonia
Community Acquired Pneumonia (CAP)
RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Asthma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Body Awareness Therapy and Standart Care in people with Asthma, run by Recep Tayyip Erdogan University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Six-Minute Walk Test Distance (time frame: Baseline (Week 0) and Post-intervention (Week 8)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026.